<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="P0b002ee1803854a6">
<name type="corporate">
 <namePart>United States Government Publishing Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
  <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
</role>
 <role>
  <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
  <roleTerm authority="marcrelator" type="code">dst</roleTerm>
</role>
</name>
<name type="corporate">
 <namePart>United States</namePart>
 <namePart>Government Accountability Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">author</roleTerm>
  <roleTerm authority="marcrelator" type="code">aut</roleTerm>
</role>
 <description>Government Organization</description>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="marcgt">government publication</genre>
<language>
 <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<extension>
 <collectionCode>GAOREPORTS</collectionCode>
 <category>Legislative Agency Publications</category>
 <waisDatabaseName>gao</waisDatabaseName>
 <branch>legislative</branch>
 <dateIngested>2010-08-12</dateIngested>
</extension>
<originInfo>
 <publisher>U.S. Government Printing Office</publisher>
 <dateIssued encoding="w3cdtf">2005-05-17</dateIssued>
 <issuance>monographic</issuance>
</originInfo>
<physicalDescription>
 <note type="source content type">deposited</note>
 <digitalOrigin>born digital</digitalOrigin>
 <extent>14 p.</extent>
</physicalDescription>
<classification authority="sudocs">GA 1.13:GAO-05-653T</classification>
<identifier type="uri">https://www.govinfo.gov/app/details/GAOREPORTS-GAO-05-653T</identifier>
<identifier type="local">P0b002ee1803854a6</identifier>
<identifier type="former package identifier">f:d05653t</identifier>
<recordInfo>
 <recordContentSource authority="marcorg">DGPO</recordContentSource>
 <recordCreationDate encoding="w3cdtf">2010-08-12</recordCreationDate>
 <recordChangeDate encoding="w3cdtf">2011-03-24</recordChangeDate>
 <recordIdentifier source="DGPO">GAOREPORTS-GAO-05-653T</recordIdentifier>
 <recordOrigin>machine generated</recordOrigin>
 <languageOfCataloging>
  <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</languageOfCataloging>
</recordInfo>
<accessCondition type="GPO scope determination">fdlp</accessCondition>
<extension>
 <docClass>REPORT</docClass>
 <accessId>GAOREPORTS-GAO-05-653T</accessId>
 <reportNumber>GAO-05-653T</reportNumber>
 <subject>Controlled substances</subject>
 <subject>Drug abuse</subject>
 <subject>Drug testing</subject>
 <subject>Drugs</subject>
 <subject>Fraud</subject>
 <subject>Internet</subject>
 <subject>Law enforcement</subject>
 <subject>Sales</subject>
 <subject>Web sites</subject>
 <subject>Drug Free Federal Workplace Program</subject>
 <type>Testimony</type>
 <accountNo>A24257</accountNo>
</extension>
<titleInfo>
 <title>Drug Tests: Products to Defraud Drug Use Screening Tests Are Widely Available</title>
</titleInfo>
<abstract>This testimony discusses the ease with which the public can
obtain products that are marketed, designed, and sold to defraud 
urine drug use screening tests such as those administered in the 
Federal Workplace Drug Testing Program. For purposes of this	 
testimony, these products will be referred to as masking products
and ways in which some businesses peddle them on the Internet	 
will be discussed. Masking products fall into one of four	 
categories: (1) dilution substances that are added to a urine	 
specimen at the time it is collected or are ingested before an	 
individual submits a urine specimen; (2) cleansing substances	 
that detoxify or cleanse the urine and are ingested prior to the 
time that an individual submits a urine specimen; (3) adulterants
that are used to destroy or alter the chemical make-up of drugs  
and are added to a urine specimen at the time that it is provided
for testing; and (4) synthetic or drug-free urine that is	 
substituted in place of an individual&apos;s specimen and provided for
testing. This testimony today summarizes our findings.</abstract>
<location>
 <url displayLabel="HTML rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-05-653T/html/GAOREPORTS-GAO-05-653T.htm</url>
 <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-05-653T/pdf/GAOREPORTS-GAO-05-653T.pdf</url>
</location>
<identifier type="preferred citation">GAO-05-653T</identifier>
<location>
 <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/GAOREPORTS-GAO-05-653T</url>
</location>
<note>Testimony</note>
<extension>
 <searchTitle>GAO-05-653T; Drug Tests: Products to Defraud Drug Use Screening Tests Are Widely Available;
            </searchTitle>
</extension>
<subject>
 <topic>Controlled substances</topic>
 <topic>Drug abuse</topic>
 <topic>Drug testing</topic>
 <topic>Drugs</topic>
 <topic>Fraud</topic>
 <topic>Internet</topic>
 <topic>Law enforcement</topic>
 <topic>Sales</topic>
 <topic>Web sites</topic>
 <topic>Drug Free Federal Workplace Program</topic>
</subject>
</mods>